tm
Seeing Is Believing
tm
Seeing Is Believing
ACRV is currently covered by 4 analysts with an average price target of $10.75. This is a potential upside of $8.95 (497.22%) from yesterday's end of day stock price of $1.8.
Acrivon Therapeutics's activity chart (see below) currently has 53 price targets and 46 ratings on display. The stock rating distribution of ACRV is 100% BUY.
Highest price target for ACRV is $14, Lowest price target is $8, average price target is $10.75.
Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 24-Mar-2026. First documented stock forecast 10-Dec-2022.
Currently out of the existing stock ratings of ACRV, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Feb-2024
$13
$11.36 (692.68%)
$13
6 months 27 days ago
(24-Mar-2026)
0/8 (0%)
$11.42 (722.78%)
Buy Since 14-Dec-2023
$14
$12.36 (753.66%)
$12
7 months 19 days ago
(01-Mar-2026)
0/2 (0%)
$12.47 (815.03%)
Buy Since 05-May-2025
$8
$6.32 (376.19%)
$6
9 months 11 days ago
(09-Jan-2026)
0/2 (0%)
$6.25 (357.14%)
Buy Since 20-Apr-2023
$19
10 months 25 days ago
(25-Nov-2025)
0/11 (0%)
$16.76 (748.21%)
Buy Since 02-Jun-2023
$8
$6.32 (376.19%)
$9
1 years 2 months 6 days ago
(14-Aug-2025)
0/4 (0%)
$6.61 (475.54%)
Which analyst most recently updated their price target on ACRV (Acrivon Therapeutics)?
Which analyst has the most public recommendations on ACRV (Acrivon Therapeutics)?
Which analyst is the currently most bullish on ACRV (Acrivon Therapeutics)?
Which analyst is the currently most reserved on ACRV (Acrivon Therapeutics)?
